Propagenix is actively seeking academic collaborators and industrial partners interested in utilizing our technologies. We welcome different business models in working with clients and collaborators.
For academic and non-profit research groups, Propagenix can provide the foundational research tools to practice its EpiX and CR technologies at a market-appropriate price. We seek partnerships with basic research groups who will share research results so that all parties can use new understandings and applications related to these emerging technologies. Propagenix appreciates the need for confidentiality ahead of publication, and will work with partners to ensure timely release of research results.
Propagenix has an active roster of sponsored programs with leading pharmaceutical and biotechnology companies who wish to pilot or expand deployment of our technologies in their discovery programs. Client-sponsored research projects include generation of more representative and patient-specific cancer models, new in vitro models for drug discovery, delivery and absorption, and improved models needed to reduce or replace the need for animal models to assess safety and toxicity of new drugs, additives, environmental pollutants and the like. Propagenix works with client companies in a milestone-based structure, which involves regular communications with the client. The ownership of data and deliverables, a technology transfer plan, and the ability to practice our technology together with the specific deliverables is built into the research agreement. We encourage potential clients to contact Propagenix using the “Contact Us” link to initiate a project request.
Propagenix entertains licensing requests from companies interested in utilizing our technologies and products for their internal research activities as well as for commercial applications. In addition, Propagenix is open to cross-licensing relationships where partnerships offer synergistic technology combinations for defined fields of use.